Literature DB >> 26240372

Ancient hot and cold genes and chemotherapy resistance emergence.

Amy Wu1, Qiucen Zhang2, Guillaume Lambert3, Zayar Khin4, Robert A Gatenby4, Hyunsung John Kim5, Nader Pourmand5, Kimberly Bussey6, Paul C W Davies7, James C Sturm1, Robert H Austin8.   

Abstract

We use a microfabricated ecology with a doxorubicin gradient and population fragmentation to produce a strong Darwinian selective pressure that drives forward the rapid emergence of doxorubicin resistance in multiple myeloma (MM) cancer cells. RNA sequencing of the resistant cells was used to examine (i) emergence of genes with high de novo substitution densities (i.e., hot genes) and (ii) genes never substituted (i.e., cold genes). The set of cold genes, which were 21% of the genes sequenced, were further winnowed down by examining excess expression levels. Both the most highly substituted genes and the most highly expressed never-substituted genes were biased in age toward the most ancient of genes. This would support the model that cancer represents a revision back to ancient forms of life adapted to high fitness under extreme stress, and suggests that these ancient genes may be targets for cancer therapy.

Entities:  

Keywords:  ancient genes; cancer; cold; emergence; hot

Mesh:

Substances:

Year:  2015        PMID: 26240372      PMCID: PMC4547268          DOI: 10.1073/pnas.1512396112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens.

Authors:  Richard Simon; Larry Norton
Journal:  Nat Clin Pract Oncol       Date:  2006-08

2.  Cell motility and drug gradients in the emergence of resistance to chemotherapy.

Authors:  Amy Wu; Kevin Loutherback; Guillaume Lambert; Luis Estévez-Salmerón; Thea D Tlsty; Robert H Austin; James C Sturm
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

Review 3.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

4.  Hierarchical evolution of animal body plans.

Authors:  Jiankui He; Michael W Deem
Journal:  Dev Biol       Date:  2009-09-30       Impact factor: 3.582

Review 5.  Latest advances and current challenges in the treatment of multiple myeloma.

Authors:  Anuj Mahindra; Jacob Laubach; Noopur Raje; Nikhil Munshi; Paul G Richardson; Kenneth Anderson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-21       Impact factor: 66.675

6.  Minimization of thermodynamic costs in cancer cell invasion.

Authors:  Liyu Liu; Guillaume Duclos; Bo Sun; Jeongseog Lee; Amy Wu; Yoonseok Kam; Eduardo D Sontag; Howard A Stone; James C Sturm; Robert A Gatenby; Robert H Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

7.  DNA polymerase δ-interacting protein 2 is a processivity factor for DNA polymerase λ during 8-oxo-7,8-dihydroguanine bypass.

Authors:  Giovanni Maga; Emmanuele Crespan; Enni Markkanen; Ralph Imhof; Antonia Furrer; Giuseppe Villani; Ulrich Hübscher; Barbara van Loon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

8.  Human housekeeping genes, revisited.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Trends Genet       Date:  2013-06-27       Impact factor: 11.639

9.  Initial genome sequencing and analysis of multiple myeloma.

Authors:  Michael A Chapman; Michael S Lawrence; Jonathan J Keats; Kristian Cibulskis; Carrie Sougnez; Anna C Schinzel; Christina L Harview; Jean-Philippe Brunet; Gregory J Ahmann; Mazhar Adli; Kenneth C Anderson; Kristin G Ardlie; Daniel Auclair; Angela Baker; P Leif Bergsagel; Bradley E Bernstein; Yotam Drier; Rafael Fonseca; Stacey B Gabriel; Craig C Hofmeister; Sundar Jagannath; Andrzej J Jakubowiak; Amrita Krishnan; Joan Levy; Ted Liefeld; Sagar Lonial; Scott Mahan; Bunmi Mfuko; Stefano Monti; Louise M Perkins; Robb Onofrio; Trevor J Pugh; S Vincent Rajkumar; Alex H Ramos; David S Siegel; Andrey Sivachenko; A Keith Stewart; Suzanne Trudel; Ravi Vij; Douglas Voet; Wendy Winckler; Todd Zimmerman; John Carpten; Jeff Trent; William C Hahn; Levi A Garraway; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  20 in total

1.  Ancestral gene regulatory networks drive cancer.

Authors:  Kimberly J Bussey; Luis H Cisneros; Charles H Lineweaver; Paul C W Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

2.  Microfluidics in Malignant Glioma Research and Precision Medicine.

Authors:  Meghan Logun; Wujun Zhao; Leidong Mao; Lohitash Karumbaiah
Journal:  Adv Biosyst       Date:  2018-04-02

Review 3.  Spatial Heterogeneity in the Tumor Microenvironment.

Authors:  Yinyin Yuan
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

4.  Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.

Authors:  Anna S Trigos; Richard B Pearson; Anthony T Papenfuss; David L Goode
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

5.  The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells.

Authors:  Ke-Chih Lin; Gonzalo Torga; Yusha Sun; Robert Axelrod; Kenneth J Pienta; James C Sturm; Robert H Austin
Journal:  Clin Exp Metastasis       Date:  2019-02-27       Impact factor: 5.150

6.  Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscape.

Authors:  Ke-Chih Lin; Gonzalo Torga; Amy Wu; Joshua D Rabinowitz; Wesley J Murray; James C Sturm; Kenneth J Pienta; Robert Austin
Journal:  Converg Sci Phys Oncol       Date:  2017-08-30

7.  Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology.

Authors:  Jeonghun Han; Yukyung Jun; So Hyun Kim; Hong-Hoa Hoang; Yeonjoo Jung; Suyeon Kim; Jaesang Kim; Robert H Austin; Sanghyuk Lee; Sungsu Park
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-22       Impact factor: 11.205

8.  Inferring initial state of the ancestral network of cellular fate decision: a case study of phage lambda.

Authors:  Yiyu Pang; Jie Liang
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2021-11

9.  Cancer progression as a sequence of atavistic reversions.

Authors:  Charles H Lineweaver; Kimberly J Bussey; Anneke C Blackburn; Paul C W Davies
Journal:  Bioessays       Date:  2021-05-13       Impact factor: 4.345

10.  Reverting to single-cell biology: The predictions of the atavism theory of cancer.

Authors:  Kimberly J Bussey; Paul C W Davies
Journal:  Prog Biophys Mol Biol       Date:  2021-08-08       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.